MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-OD-19-0014242
Xyiris Pharmaceuticals Private Limited
Xyiris Pharmaceuticals Private Limited - chemicals in Bhubaneswar, Odisha, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹35.95 Lakh
▲ 20% YoY
Net profit · FY 2025
₹2.04 Lakh
Net margin 5.7%
EBITDA · FY 2025
₹2.94 Lakh
EBITDA margin 8.2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹5 Lakh
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
About Xyiris Pharmaceuticals Private Limited
Data last updated:
Xyiris Pharmaceuticals Private Limited is a private limited company based in Bhubaneswar, Odisha, India. It operates in the basic organic chemical segment of the chemicals sector. It was incorporated on 27 March 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U24119OR2020PTC032881. Its GSTIN is 21AAACX3242Q1Z8 (Odisha).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Truptirani Mangaraj (Managing Director) and Ashok Kumar Subudhi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bhubaneswar, Odisha.
As per the financials filed for FY 2025, the company reported a revenue of ₹35.95 Lakh, a growth of 20% compared to the previous year. For the same year it recorded a net profit of ₹2.04 Lakh (net margin 5.7%) and EBITDA of ₹2.94 Lakh (EBITDA margin 8.2%). Revenue has grown at a compounded annual rate (CAGR) of 40% over three years.
The company is associated with 1 brand: Xyiris Pharmaceuticals. As per MCA filings, the company has open charges of ₹5 Lakh on record.
Xyiris Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-OD-19-0014242).
Company details
CIN U24119OR2020PTC032881
Registration Number 032881
Incorporation Date 27 March 2020
ROC Cuttack
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-OD-19-0014242
Recognitions & Rankings of Xyiris Pharmaceuticals
Contact details
Xyiris Pharmaceuticals Private Limited's registered office is in Bhubaneswar, Odisha. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No – 658 Ground Floor At/Po – Bharatpur Near Kalinga Studio Chhaka Andharua Ps, Khandagir, Bhubaneswar, Odisha, India – 751003
- IndustryChemicals, Basic Organic Chemical, Basic Chemicals Except Fertilizers And Nitrogen Compounds, Manufacturing, Basic Chemical
To see the full contact details of Xyiris Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Xyiris Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Xyiris Pharmaceuticals operates one associated brand: XYIRIS PHARMACEUTICALS. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Eye care products and treatments for conditions like Dry Eye, Glaucoma, and ARMD in India. | xyirispharmaceuticals.com |
Business activity
The main business activity of Xyiris Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Xyiris Pharmaceuticals Private Limited, buy the company report.
Financials of Xyiris Pharmaceuticals Private Limited
FY 2025 filings availableXyiris Pharmaceuticals Private Limited reported revenue of ₹35.95 Lakh (up 20% YoY) for FY 2025.
Revenue · FY 2025
₹35.95 Lakh ▲ 20%
Net profit · FY 2025
₹2.04 Lakh margin 5.7%
EBITDA · FY 2025
₹2.94 Lakh margin 8.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 20%
3 years · compounded
▲ 40%
EBITDA CAGR growth
1 year
▲ 13%
3 years · compounded
▲ 86%
Revenue has grown at a compounded annual rate (CAGR) of 40% over three years, including 20% growth in the latest year. EBITDA rose 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.94 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.04 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.2% | ||||
| Net Profit Margin | 5.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Xyiris Pharmaceuticals Private Limited, buy the company report.
Board of directors of Xyiris Pharmaceuticals Private Limited
Xyiris Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Truptirani Mangaraj | Managing Director | 27 Mar 2020 | 6 Years 6 Months | Current |
| Ashok Kumar Subudhi | Director | 27 Mar 2020 | 6 Years 6 Months | Current |
Charges & borrowings
Open charges
₹5 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Feb 2023 | 100689220 | State Bank of India | ₹5 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Xyiris Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Xyiris Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Xyiris Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 21AAACX3242Q1Z8 | Odisha | Active | 22 Jun 2020 |
To see the full GST registrations and return filing status of Xyiris Pharmaceuticals Private Limited, buy the company report.
Recent activity
Xyiris Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Ashok Kumar Subudhi was appointed as Director on 27 Mar 2020.
AGM
Xyiris Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Xyiris Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Cuttack.
Charges
A charge with State Bank Of India amounted to Rs. 5.00 Lakh with Charge ID 100689220 was registered on 24 Feb 2023.
Appointed
Ashok Kumar Subudhi was appointed as Director.
Appointed
Truptirani Mangaraj was appointed as Managing Director.
Incorporation
27 Mar 2020
Xyiris Pharmaceuticals Private Limited was registered on 27 Mar 2020 with Roc Cuttack & aged 6 years 7 months as per MCA records.
Frequently asked questions
Xyiris Pharmaceuticals is an active private limited company based in Bhubaneswar, Odisha, India. The company works in basic organic chemical, within the chemicals industry. It was incorporated on 27 March 2020 (6+ years old) and is registered under CIN U24119OR2020PTC032881.
Xyiris Pharmaceuticals has 2 current directors:
- Truptirani Mangaraj - Managing Director
- Ashok Kumar Subudhi - Director
The latest financial statements of Xyiris Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Xyiris Pharmaceuticals is 21AAACX3242Q1Z8, registered in Odisha.
The CIN (Corporate Identification Number) of Xyiris Pharmaceuticals is U24119OR2020PTC032881. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Xyiris Pharmaceuticals was incorporated on 27 March 2020, making it 6+ years old. It is registered with the Registrar of Companies, Cuttack.
Ashok Kumar Subudhi was appointed as Director on 27 Mar 2020. Truptirani Mangaraj was appointed as Managing Director on 27 Mar 2020.
Yes, Xyiris Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-OD-19-0014242).
The registered office of Xyiris Pharmaceuticals is at Plot No – 658 Ground Floor AtPo – Bharatpur Near Kalinga Studio Chhaka Andharua Ps, Khandagir, Bhubaneswar, Odisha, India – 751003.
Xyiris Pharmaceuticals operates in the chemicals industry, in the basic organic chemical segment.